MX9201825A - Composicion farmaceutica que contiene calcitonina. - Google Patents

Composicion farmaceutica que contiene calcitonina.

Info

Publication number
MX9201825A
MX9201825A MX9201825A MX9201825A MX9201825A MX 9201825 A MX9201825 A MX 9201825A MX 9201825 A MX9201825 A MX 9201825A MX 9201825 A MX9201825 A MX 9201825A MX 9201825 A MX9201825 A MX 9201825A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
composition containing
containing calcitonin
calcitonin
calcium deficiency
Prior art date
Application number
MX9201825A
Other languages
English (en)
Inventor
Tudor Arvinte
Amelia Cudd
Judith Phillips
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MX9201825A publication Critical patent/MX9201825A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
MX9201825A 1991-04-23 1992-04-21 Composicion farmaceutica que contiene calcitonina. MX9201825A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108634A GB9108634D0 (en) 1991-04-23 1991-04-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX9201825A true MX9201825A (es) 1992-10-01

Family

ID=10693744

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9201825A MX9201825A (es) 1991-04-23 1992-04-21 Composicion farmaceutica que contiene calcitonina.

Country Status (19)

Country Link
US (1) US5593962A (es)
EP (1) EP0510913B1 (es)
JP (1) JP3532580B2 (es)
KR (1) KR100245534B1 (es)
AT (1) ATE194775T1 (es)
AU (1) AU653395B2 (es)
CA (1) CA2066532C (es)
CY (1) CY2246B1 (es)
DE (1) DE69231263T2 (es)
DK (1) DK0510913T3 (es)
ES (1) ES2150418T3 (es)
GB (1) GB9108634D0 (es)
GR (1) GR3034414T3 (es)
IE (1) IE921278A1 (es)
IL (1) IL101622A (es)
MX (1) MX9201825A (es)
NZ (1) NZ242440A (es)
PT (1) PT510913E (es)
ZA (1) ZA922899B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
JP2002539172A (ja) * 1999-03-17 2002-11-19 ノバルティス アクチエンゲゼルシャフト Ｔｇｆ−ベータを含む医薬組成物
CA2399505C (en) 2000-02-04 2012-01-03 Unigene Laboratories, Inc. Nasal calcitonin formulations
US7884071B2 (en) 2002-09-27 2011-02-08 Zentaris Gmbh Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
GB0422644D0 (en) * 2004-10-12 2004-11-10 Novartis Ag Organic compounds
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
WO2009125423A2 (en) 2008-04-07 2009-10-15 National Institute Of Immunology Compositions useful for the treatment of diabetes and other chronic disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions

Also Published As

Publication number Publication date
DE69231263T2 (de) 2000-12-21
IE921278A1 (en) 1992-11-04
GB9108634D0 (en) 1991-06-12
EP0510913A3 (en) 1993-12-15
ATE194775T1 (de) 2000-08-15
ZA922899B (en) 1993-10-22
NZ242440A (en) 1993-10-26
IL101622A0 (en) 1992-12-30
KR100245534B1 (ko) 2000-03-02
CA2066532C (en) 2003-08-19
EP0510913B1 (en) 2000-07-19
AU1506692A (en) 1992-10-29
IL101622A (en) 1996-06-18
CY2246B1 (en) 2003-07-04
JP3532580B2 (ja) 2004-05-31
JPH05139993A (ja) 1993-06-08
CA2066532A1 (en) 1992-10-24
DE69231263D1 (de) 2000-08-24
ES2150418T3 (es) 2000-12-01
AU653395B2 (en) 1994-09-29
PT510913E (pt) 2000-12-29
GR3034414T3 (en) 2000-12-29
DK0510913T3 (da) 2000-10-16
US5593962A (en) 1997-01-14
EP0510913A2 (en) 1992-10-28

Similar Documents

Publication Publication Date Title
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
MX9204229A (es) Trifluorometilbencilfosfonatos utiles en el tratamiento de osteoporosis.
DE68909691D1 (de) Multischichtkörper zur Abgabe von Duftstoffen.
DE69019363D1 (de) Desinfizierende zusammensetzung und desinfektionsverfahren.
HUT71550A (en) Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis
DE69010162D1 (de) Zusammensetzung zur Behandlung von Entzündung.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ES2164684T3 (es) Uso de antagonistas de taquiquininas en el tratamiento de emesis.
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
SE9802937D0 (sv) Novel compounds
DE3864210D1 (de) Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
KR100292396B1 (es)
MX9201825A (es) Composicion farmaceutica que contiene calcitonina.
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
ES2078904T3 (es) Nuevos derivados de neplanocina.
DE69832722D1 (de) L-threonat-eisen, pharmazeutische zusammensetzung und verwendung zur verbesserung und behandlung von anämie bei menschen
MX9202507A (es) Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
ES2154018T3 (es) Soluciones inyectables por via parenteral que contienen piroxicam.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE68900892D1 (de) Zusammenstellung zur behandlung der osteoporose beim menschen.
MX9302142A (es) Uso de 3r- y 3r,s-difenilmetoxi-1-(3,4-metileno-dioxifenetil)-piperidina y composicion que la contienen.
DK0495226T3 (da) Anvendelse af 3-aryl-5-alkylthio-4H-1,2,4-triazoler til behandling af hyperrefleksi som følge af spinaltrauma
ES2055421T3 (es) Uso de clormetiazol en la fabricacion de un medicamento para la prevencion y/o el tratamiento de neurodegeneracion.
PT661058E (pt) Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais

Legal Events

Date Code Title Description
FG Grant or registration
GD Licence granted
MM Annulment or lapse due to non-payment of fees